Recurrent Scapular Metastasis From Hepatoblastoma Shown on FDG PET/CT and F-DOPA PET/CT.

We report the case of a 4-year-old girl with a biochemical relapse (plasma α-fetoprotein of 57,987.6 μg/L) after hepatoblastoma and extrahepatic metastases removal and adjuvant chemotherapy. Abdominal ultrasound, CT, and MRI failed to determine the site of recurrence. F-FDG PET/CT showed increased activity in the region of left scapula and adjacent soft tissue, which was incorrectly interpreted as the postoperative repair or inflammatory change. F-DOPA PET/CT showed increased activity and noticeable progressed lesion in the same place. Finally, the left scapula was identified as the site of recurrent metastasis from hepatoblastoma by pathological examination.

[1]  N. Shah,et al.  Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  G. Mariani,et al.  Role of 18F-DOPA PET/CT in Diagnosis and Follow-up of Adrenal and Extra-adrenal Paragangliomas , 2014, Clinical nuclear medicine.

[3]  Michael E. Phelps,et al.  18F-FDOPA PET for Differentiating Recurrent or Progressive Brain Metastatic Tumors from Late or Delayed Radiation Injury After Radiation Treatment , 2014, The Journal of Nuclear Medicine.

[4]  U. Ficola,et al.  A Comparison between 18F-FDG PET/CT Imaging and Biological and Radiological Findings in Restaging of Hepatoblastoma Patients , 2013, BioMed research international.

[5]  R. Hofstra,et al.  Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma , 2012, The Journal of Nuclear Medicine.

[6]  C. Nanni,et al.  18F-DOPA PET/CT in Neuroblastoma: Comparison of Conventional Imaging With CT/MR , 2012, Clinical nuclear medicine.

[7]  H. Minn,et al.  The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors. , 2008, Endocrine-related cancer.

[8]  A. Alavi,et al.  Fluorine-18 DOPA-PET and PET/CT Imaging in Congenital Hyperinsulinism. , 2008, PET clinics.

[9]  Janet R. Saffer,et al.  Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. , 2007, The Journal of clinical endocrinology and metabolism.

[10]  A. Alavi,et al.  Positron Emission Tomography Imaging and Hyperinsulinism. , 2007, PET clinics.

[11]  Janet R. Saffer,et al.  Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. , 2007, The Journal of pediatrics.

[12]  Samuel A. McQuiston,et al.  Recurrent hepatoblastoma with localization by PET-CT , 2005, Pediatric Radiology.

[13]  G. McCowage,et al.  Positron emission tomography in recurrent hepatoblastoma , 2005, Pediatric Surgery International.